Volume-Based Tube Feeding for Critically Ill Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method of feeding critically ill children in the hospital to determine if it improves their nutrition. The standard method, rate-based enteral nutrition (EN), feeds at a set rate. This trial will evaluate whether monitoring the total amount fed throughout the day, known as volume-based enteral nutrition (EN), is more effective. Children who have stayed in the hospital's Pediatric Intensive Care Unit for at least 48 hours and require tube feeding may qualify for this study. The goal is to discover if this new feeding method can enhance the children's recovery and hospital stay. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve care for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It focuses on tube feeding methods for critically ill children.
What prior data suggests that this volume-based feeding algorithm is safe for critically ill children?
Research has shown that volume-based feeding can safely improve nutrition in very sick patients. One study found that this method significantly increased the calories and protein patients received without adding extra risk. This indicates that the volume-based approach is well-tolerated. No additional negative effects have been reported with this method. Based on this evidence, it appears to be a safe option for improving nutrition in hospitalized children who need tube feeding.12345
Why are researchers excited about this trial?
Researchers are excited about the volume-based enteral nutrition (EN) approach for critically ill children because it offers a more tailored way to meet each child's nutritional needs. Unlike the standard rate-based EN, which delivers nutrition at a constant rate, the volume-based method adjusts the feeding volume based on the child's tolerance and nutritional requirements. This could potentially enhance nutritional delivery, improve recovery times, and reduce the risk of complications associated with underfeeding or overfeeding. By customizing the nutritional intake, this method aims to provide more effective and responsive care for critically ill children.
What evidence suggests that this trial's feeding algorithms could be effective for critically ill children?
Research has shown that a volume-based feeding plan, one of the treatment arms in this trial, can significantly improve the delivery of necessary calories and protein to critically ill patients without increasing risks. One study found that children fed using this method experienced fewer interruptions in their feeding. Another study reported that from 2021 to 2024, the percentage of critically ill patients reaching their feeding goals rose from 62% to 86% with volume-based feeding. Additionally, this method has been shown to reduce the risk of death by 15%. Overall, these findings suggest that volume-based feeding can enhance nutrition delivery and potentially lead to better health outcomes in critically ill children. Meanwhile, the trial will also evaluate the rate-based feeding plan, which serves as the standard of care comparator.12367
Who Is on the Research Team?
Tanis Fenton, PhD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for critically ill children aged 1 month to 18 years who are expected to stay in the Pediatric Intensive Care Unit (PICU) for at least 48 hours and need tube feeding. It excludes those not meeting these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either volume-based or rate-based enteral nutrition algorithms in the PICU
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of nutrition adequacy and clinical outcomes
Deferred Consent Evaluation
Evaluation of the deferred consent strategy through qualitative interviews with caregivers and patients
What Are the Treatments Tested in This Trial?
Interventions
- Rate-based EN
- Volume-based EN
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator
American Society for Parenteral and Enteral Nutrition
Collaborator